Lipocine Inc. (LPCN)
NASDAQ: LPCNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 2.05 -6.70%
LPCN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $18.14M
- EPS (TTM)
- -$1.85
- Dividend yield
- None
- 52-week range
- 1.81 – 12.37
- Day range
- 2.07 – 3.14
- Volume / Avg
- 105.18M / 35.40K
- Beta
- —
- Shares outstanding
- 8.24M
- Next earnings
- Nov 5, 2026
52-week range
LPCN stock today
Shares of Lipocine (LPCN) finished higher on Oct 7 at $2.20, a gain of 4.76% or $0.10 per share, versus the S&P 500's 0.22% decline. Volume was 2971.1x the average at 105.18M shares, a sign of unusually heavy trading. Shares are 82.2% below their 52-week high of $12.37, set on Jan 15, 2026 and 21.5% above the 52-week low of $1.81, near the bottom of the past year's range.
LPCN is down 72.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 31.7%. Lipocine has posted a net loss over the last twelve months (EPS of -$1.85), so its P/E ratio is not meaningful. Lipocine's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Lipocine
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Salt Lake City
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.39
Lipocine peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NEUPNeuphoria Therapeutics Inc. | 3.42 | -0.29% | $18.51M | vs LPCN |
| NCELNewcelX Ltd. | 3.04 | +2.51% | $17.53M | vs LPCN |
| ACTUActuate Therapeutics Inc. | 0.7242 | -10.77% | $17.39M | vs LPCN |
| MRKRMarker Therapeutics Inc. | 1.04 | +2.97% | $17.34M | vs LPCN |
| PTNPalatin Technologies Inc. | 9.52 | +1.17% | $16.95M | vs LPCN |
| RADXRadiopharm Theranostics Limited ADR | 1.15 | -2.54% | $16.78M | vs LPCN |
| RKTORocket One Inc. | 0.67 | -4.48% | $16.68M | vs LPCN |
| AKTXAkari Therapeutics plc ADS | 8.63 | +2.80% | $19.71M | vs LPCN |
Indexes, lists and sector
Lipocine stock FAQ
What is Lipocine's stock price today?
LPCN last traded at $2.20 as of Oct 7, 4:00 PM EDT, up 4.76% on the day. Prices are delayed at least 15 minutes.
Does Lipocine pay a dividend?
No. Lipocine does not currently pay a regular cash dividend.
When is Lipocine's next earnings date?
Lipocine is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.39.
Has LPCN ever split its stock?
Yes. The most recent LPCN stock split was a 1-for-17 split on May 12, 2023.
What is the LPCN 52-week high?
The 52-week high for LPCN is $12.37 and the 52-week low is $1.81. The stock is currently 82.2% below its high.